Detection and Confirmation of novel serum lipid biomarkers predicting Preeclampsia using a Shotgun lipidomics approach

摘要

Promising panels of validated serum PE lipidomic markers are likely to predict patients at risk for PE at 12-14 weeks of pregnancy. Studies to further validate these markers is needed; the markers also suggest pathologies present months prior to appearance of any clinical manifestations of PE.